Malaysia Dengue Treatment Market to be Dominated by Vaccine Type Through 2028
Rising
prevalence of dengue and increasing research and development are expected to
drive the Malaysia Dengue Treatment Market in the forecast period, 2024-2028.
According to TechSci Research
report, “Malaysia Dengue Treatment
Market – By
Region, Competition Forecast and Opportunities, 2018-2028,” the Malaysia Dengue Treatment
Market is anticipated to grow at a significant rate in the forecast period,
2024-2028. The driving force behind this growth is the rising research and
development in the country for the production of new and effective drugs for
the widely prevalent dengue. In Malaysia, dengue is a significant public health
issue. According to WHO estimates, 182 deaths were reported in Malaysia in
2019. The country has taken various measures to control the spread of the
disease, including vector control measures and public education campaigns.
However, there is still a need for more effective treatments for dengue, given
the significant impact of the disease on public health.
One of
the factors driving the increase in R&D efforts for dengue treatment is the
availability of funding. Various organizations, including government agencies
and private foundations, have committed significant resources to support
research in this area, propelling the growth of the Malaysia Dengue Treatment
Market in the forecast period. For example, the Malaysian government has
allocated funds to support research on dengue, including the development of new
treatment options.
Another
factor driving the increase in R&D is the advancement of technology. New
technologies, such as gene editing and CRISPR, are being used to develop
innovative approaches to treating dengue. These technologies offer new
possibilities for developing targeted therapies that can be more effective than
current treatment options, which is likely to fuel the Malaysia Dengue
Treatment Market over the forecast period.
However, the high cost
of dengue treatment, the unavailability of any specific antiviral medication
for dengue treatment, the unawareness about dengue prevention among people
belonging to underdeveloped areas, and the limited coverage of dengue treatment
drugs may hamper the market's growth in the forecast period.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on “Malaysia Dengue Treatment Market”
The Malaysia
Dengue Treatment Market is segmented into Type, Route of Administration, End-users, Region and Company.
Based on type, the market is divided into
drugs and vaccines. The vaccine segment is expected to witness a rise over the
forecast period. This is attributed to the fact that vaccines help lower the
risk of certain illnesses by introducing disease-causing germs (bacteria or
viruses) that are dead or weakened to the immune system and stimulating the
production of antibodies to provide immunity against one or more diseases. This
is anticipated to support market growth in the future.
Based on Route
of Administration, the market is divided into Oral and Parenteral. The Oral
segment is expected to witness a rise over the forecast period. This is
attributed to the cost effectiveness and the convenience of oral route of drug
administration. When administering medications orally, the first-pass effect is
a crucial factor to take into account. It refers to the process of drug
metabolism in which, frequently as a result of liver metabolism, the drug
concentration is significantly reduced before it reaches the systemic
circulation.
Based on End-users,
the market is divided into Hospitals,
Specialty Clinic, Homecare, and Others. The Hospitals segment is expected to witness a rise over the
forecast period. This is attributed to the availability of skilled
professionals and high-quality treatment equipment which is expected to propel market
growth.
Major companies
operating in Malaysia Dengue Treatment Market are:
- Johnson & Johnson
- Novartis Corporation (Malaysia) Sdn.
Bhd.
- Otsuka Pharmaceuticals (Malaysia) Sdn.
Bhd.
- GSK Malaysia
- Roche Holding Ag Malaysia.
- Sanofi-Aventis (Malaysia) Sdn. Bhd
- Bayer Co. (Malaysia) Sdn Bhd
- Merck Sdn Bhd
Download Free Sample Report
Customers can also request 10% free customization in this
report.
“The Malaysia Dengue Treatment Market is expected to witness
significant growth in the upcoming years due to the growing prevalence of
dengue in the nation. Additionally, increasing government initiatives and
funding are leading to increased research and development for the production of
new drugs and vaccines in the market. Moreover, technological advancements in
the pharmaceutical industry, as well as rising awareness regarding the
prevention of dengue, are strengthening the market's growth. It is expected to
continue growing through 2028," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based global management consulting firm.
“Malaysia Dengue Treatment Market By Type (Drug and
Vaccine), By Route of Administration (Oral and Parenteral), By End-users
(Hospitals, Specialty Clinic, Homecare, and Others), By Region, Competition
Forecast & Opportunities, 2018-2028F,” has evaluated the future
growth potential of Malaysia Dengue Treatment Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Malaysia Dengue Treatment Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web: https://www.techsciresearch.com